Christopher Gerard - Net Worth and Insider Trading

Christopher Gerard Net Worth

The estimated net worth of Christopher Gerard is at least $4 Million dollars as of 2024-05-22. Christopher Gerard is the President & COO of Amedisys Inc and owns about 38,135 shares of Amedisys Inc (AMED) stock worth over $4 Million. Details can be seen in Christopher Gerard's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christopher Gerard has not made any transactions after 2021-08-02 and currently still holds the listed stock(s).

Transaction Summary of Christopher Gerard

To

Christopher Gerard Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher Gerard owns 1 companies in total, including Amedisys Inc (AMED) .

Click here to see the complete history of Christopher Gerard’s form 4 insider trades.

Insider Ownership Summary of Christopher Gerard

Ticker Comapny Transaction Date Type of Owner
AMED Amedisys Inc 2021-08-02 Chief Operating Officer

Christopher Gerard Latest Holdings Summary

Christopher Gerard currently owns a total of 1 stock. Christopher Gerard owns 38,135 shares of Amedisys Inc (AMED) as of August 2, 2021, with a value of $4 Million.

Latest Holdings of Christopher Gerard

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AMED Amedisys Inc 2021-08-02 38,135 96.21 3,668,968

Holding Weightings of Christopher Gerard


Christopher Gerard Form 4 Trading Tracker

According to the SEC Form 4 filings, Christopher Gerard has made a total of 20 transactions in Amedisys Inc (AMED) over the past 5 years, including 0 buys and 20 sells. The most-recent trade in Amedisys Inc is the sale of 1,250 shares on August 2, 2021, which brought Christopher Gerard around $326,550.

Insider Trading History of Christopher Gerard

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christopher Gerard Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Christopher Gerard Ownership Network

Ownership Network List of Christopher Gerard

No Data

Ownership Network Relation of Christopher Gerard


Christopher Gerard Owned Company Details

What does Amedisys Inc do?

Who are the key executives at Amedisys Inc?

Christopher Gerard is the Chief Operating Officer of Amedisys Inc. Other key executives at Amedisys Inc include Chief Accounting Officer Allyson Guidroz , director & President and CEO Richard M Ashworth , and Chief Information Officer Michael Paul North .

Amedisys Inc (AMED) Insider Trades Summary

Over the past 18 months, Christopher Gerard made no insider transaction in Amedisys Inc (AMED). Other recent insider transactions involving Amedisys Inc (AMED) include a net sale of 5,908 shares made by Michael Paul North ,

In summary, during the past 3 months, insiders sold 0 shares of Amedisys Inc (AMED) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,908 shares of Amedisys Inc (AMED) were sold and 0 shares were bought by its insiders, resulting in a net sale of 5,908 shares.

Amedisys Inc (AMED)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Amedisys Inc Insider Transactions

No Available Data

Christopher Gerard Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher Gerard. You might contact Christopher Gerard via mailing address: 3854 American Way, Suite A, Baton Rouge La 70816.

Discussions on Christopher Gerard

No discussions yet.